Is MA Financials Aged Care Exit a Smart Move for Growth?
Source: Kapitales Research
Highlights:
MA Financial Group Limited (ASX: MAF) shares fell 2.6% to $9.00 (at the time of writing) after announcing the sale of Infinite Care to Anglicare Sydney.
The MA Aged Care Fund exit will deliver investors more than 2.8x their original invested capital, while MA Financial expects to book a ~$20 million co-investment gain plus a performance fee.
Proceeds from the sale will be recycled into new growth initiatives as the group continues expanding its alternative asset management platform.
MA Financial Shares Slip Despite Strong Fund Returns
MA Financial Group Limited (ASX: MAF) saw its shares trade lower on 2 March 2026 after announcing the sale of its aged care asset. At the time of writing, the shares were trading at $9.00, reflecting a decline of 24 cents, or 2.597%. The alternative asset manager oversees $15.3 billion in assets under management, manages $175 billion in loans, and has advised on more than $135 billion in corporate advisory and ECM transactions (as at 31 December 2025). The company confirmed that, through its MA Aged Care Fund, it has agreed to sell Infinite Care to Anglicare Sydney for an undisclosed amount. Completion of the deal is targeted for the first half of FY26, contingent on customary regulatory and closing approvals.
Robust Gains for Investors
The sale marks the exit of the sole asset held within the MA Aged Care Fund and is set to deliver investors a total return exceeding 2.8 times their original invested capital, net of fees, over the life of the fund. MA Financial will also benefit directly. The group expects to record a gain of approximately $20 million from its co-investment in the fund. This profit will be treated as a one-off significant item in FY26 earnings. In addition, the firm will earn a performance fee linked to the fund’s outcome, with the final amount dependent on customary completion adjustments. Management said the cash proceeds from both the investment gain and performance fee would be redeployed into future growth opportunities.
Strategic Impact
The acquisition will see Infinite Care integrated into Anglicare Sydney’s platform, forming a larger national residential aged care provider. The combined entity is expected to pursue expansion opportunities, including the development of new aged care beds. For MA Financial, the deal reinforces its strategy of actively managing assets to unlock value — even as short-term share price movements reflect broader market sentiment.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), aare intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Is MA Financials Aged Care Exit a Smart Move for Growth?
Highlights:
MA Financial Shares Slip Despite Strong Fund Returns
MA Financial Group Limited (ASX: MAF) saw its shares trade lower on 2 March 2026 after announcing the sale of its aged care asset. At the time of writing, the shares were trading at $9.00, reflecting a decline of 24 cents, or 2.597%. The alternative asset manager oversees $15.3 billion in assets under management, manages $175 billion in loans, and has advised on more than $135 billion in corporate advisory and ECM transactions (as at 31 December 2025). The company confirmed that, through its MA Aged Care Fund, it has agreed to sell Infinite Care to Anglicare Sydney for an undisclosed amount. Completion of the deal is targeted for the first half of FY26, contingent on customary regulatory and closing approvals.
Robust Gains for Investors
The sale marks the exit of the sole asset held within the MA Aged Care Fund and is set to deliver investors a total return exceeding 2.8 times their original invested capital, net of fees, over the life of the fund. MA Financial will also benefit directly. The group expects to record a gain of approximately $20 million from its co-investment in the fund. This profit will be treated as a one-off significant item in FY26 earnings. In addition, the firm will earn a performance fee linked to the fund’s outcome, with the final amount dependent on customary completion adjustments. Management said the cash proceeds from both the investment gain and performance fee would be redeployed into future growth opportunities.
Strategic Impact
The acquisition will see Infinite Care integrated into Anglicare Sydney’s platform, forming a larger national residential aged care provider. The combined entity is expected to pursue expansion opportunities, including the development of new aged care beds. For MA Financial, the deal reinforces its strategy of actively managing assets to unlock value — even as short-term share price movements reflect broader market sentiment.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), aare intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au